073 Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune modifying therapies: a nationwide cohort study in the OpenSAFELY platform

Detalles Bibliográficos
Autores principales: Langan, S., Smith, C., Collaborative, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672437/
http://dx.doi.org/10.1016/j.jid.2022.09.083
Descripción
Sumario:

Ejemplares similares